Annual Report to the Nation: Declines in lung cancer, melanoma death rates drive overall cancer mortality drop

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

From 2015 to 2018, the overall cancer death rate in the United States fell by 2.3% per year for men and 2.1% per year for women—an unprecedented drop, led by accelerated decline in deaths from lung cancer and melanoma.

By way of comparatison, the death rate for men dropped 1.8% per year from 2001-2015, and the death rate in women declined 1.4% per year from 2001-2015, according to this year’s Annual Report to the Nation, a study conducted by several federal agencies and cancer groups.

The report, published in JNCI: The Journal of the National Cancer Institute, also finds that overall cancer incidence rates continue to increase among females, children, adolescents and young adults. All trends in this report cover the period before the COVID-19 pandemic.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Alexandria Carolan
Alexandria Carolan
Reporter

YOU MAY BE INTERESTED IN

Twenty years ago, the discovery of epidermal growth factor receptor mutations as drivers of tumorigenesis and viable targets for therapeutic intervention marked the beginning of a new era in lung cancer diagnosis and treatment. Since then, the field has made remarkable progress towards developing more effective targeted treatments and immunotherapies that have significantly improved patient outcomes and survival.
Alexandria Carolan
Alexandria Carolan
Reporter

Login